Employees: 12 (2023.0)Legal category: 5785Size: PMECreation date: 2009-11-15 (16 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: NOISY-LE-GRAND (93160), Seine-Saint-Denis
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE CENTRE COMMERCIAL MONT D'EST : revenue, balance sheet and financial ratios
PHARMACIE CENTRE COMMERCIAL MONT D'EST is a French company
founded 16 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in NOISY-LE-GRAND (93160),
this company of category PME
shows in 2024 a net income positive of 396 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE CENTRE COMMERCIAL MONT D'EST (SIREN 517791604)
Indicator
2024
2023
2022
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
Net income
395 722 €
1 200 628 €
937 159 €
170 544 €
274 015 €
303 185 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE CENTRE COMMERCIAL MONT D'EST generates positive net income of 396 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 303 k€ -> 396 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
395 722 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 621%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 12%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
620.945%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
11.841%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE CENTRE COMMERCIAL MONT D'EST
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2022
2023
2024
Debt ratio
474.092
340.868
278.856
217.357
1384.154
620.945
Financial autonomy
14.31
18.411
20.868
23.389
5.839
11.841
Repayment capacity
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
620.952024
2022
2023
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Average
In 2024, the debt ratio of PHARMACIE CENTRE COMMERCI... (620.95) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
11.84%2024
2022
2023
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Watch
In 2024, the financial autonomy of PHARMACIE CENTRE COMMERCI... (11.8%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 244.29. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
244.286
Liquidity indicators evolution PHARMACIE CENTRE COMMERCIAL MONT D'EST
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2022
2023
2024
Liquidity ratio
158.756
153.26
140.046
225.71
278.829
244.286
Interest coverage
None
None
None
None
None
None
Sector positioning
Liquidity ratio
244.292024
2022
2023
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Good+11 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE CENTRE COMMERCI... (244.29) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE CENTRE COMMERCIAL MONT D'EST in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE CENTRE COMMERCIAL MONT D'EST is estimated at
5 524 571 €
(range 3 847 224€ - 8 265 075€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
3847k€5524k€8265k€
5 524 571 €Range: 3 847 224€ - 8 265 075€
NAF 5 année 2024
Valuation method used
Net Income Multiple
395 722 €
×
14.0x
=5 524 572 €
Range: 3 847 224€ - 8 265 075€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE CENTRE COMMERCIAL MONT D'EST with other companies in the same sector:
Frequently asked questions about PHARMACIE CENTRE COMMERCIAL MONT D'EST
What is the revenue of PHARMACIE CENTRE COMMERCIAL MONT D'EST ?
The revenue of PHARMACIE CENTRE COMMERCIAL MONT D'EST is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE CENTRE COMMERCIAL MONT D'EST profitable?
Yes, PHARMACIE CENTRE COMMERCIAL MONT D'EST generated a net profit of 396 k€ in 2024.
Where is the headquarters of PHARMACIE CENTRE COMMERCIAL MONT D'EST ?
The headquarters of PHARMACIE CENTRE COMMERCIAL MONT D'EST is located in NOISY-LE-GRAND (93160), in the department Seine-Saint-Denis.
Where to find the tax return of PHARMACIE CENTRE COMMERCIAL MONT D'EST ?
The tax return of PHARMACIE CENTRE COMMERCIAL MONT D'EST is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE CENTRE COMMERCIAL MONT D'EST operate?
PHARMACIE CENTRE COMMERCIAL MONT D'EST operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart